TCTR20170621002尚未招募2 期
Efficacy and Safety of Thai Herbal Formularies Benja Amarit in Hepatocellular Carcinoma Patients: Clinical Trial Phase II
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 81
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •1. Patients who have been diagnosed is Hepatocellular carcinoma Child-Pugh score class A OR B.
- •2. Patients who cannot treat by standard treatment.
- •3. Stop another treatment not less than 4 weeks.
- •4. Stop radiation and chemotherapy not less than 4 weeks.
- •5. Thai, age between 18-80 years.
- •6. Zubrod-ECOG-WHO score between 0-2.
- •7. Patients who was evaluated to survival more than 5 months.
- •- To understand Thai language and to communicate with research assistants to assess side effects from treatment
- •- Can receive medication and follow up as prescribed
- •- Consent and sign the name in research
排除标准
- •1. Patients who have been allergy to ingredient of formularies Benja Amarit
- •2. Pregnant or breastfeeding women.
- •3. Receive chemotherapy or use herb or vitamin, its out of standard treatment.
- •4. Patient who have acute illness such as sepsis.
研究者
相似试验
已完成
2 期
Integrative medicine for liver cancer patients with no definitive treatment: A pilot projectHepatocellular carcinoma is the major cancer problem in Thailand. The treatment for the advanced disease is still very limited. Targeted therapy is very expensive and cannot distributed to all patherbal recipethree rootshepatocellular carcinomaTCTR20180611001Thai Traditional Medical Knowledge Fund20
Unknown
1 期
Safety of Thai Traditional Medicine Recipes and Herbal Drink in Healthy VolunteersThere have been no scientific studies confirming toxicity. Therefore, to ensure that the dosage of Thai Traditional Medicine Recipes and Herbal Drink is safe and can be used for further research in Phase 2 in patients with COVID-19.COVID-19, Ha-rak, Ha-rak (Kun-So-Pit), Juntaleela, Fataliajorn-Prasa, Herbal drinkTCTR20211227002Giving Mind Nirvana Soul Foundation32
已完成
3 期
Efficacy and Safety of an Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence: A Prospective, Placebo Controlled, Randomized, double-blinded Parallel-Group Comparison for SuperiorityAcute Otitis Media (AOM)H65.0 und H66.0Upper respiratory tract infectionH65.0H66.0Acute serous otitis mediaAcute suppurative otitis mediaDRKS00004569Weber & Weber GmbH & Co. KGBiologische Arzneimittel311
进行中（未招募）
不适用
Does a herbal-based medicine compared with a placebo (dummy drug) reduce the number of episodes with middle ear infection?recurrent acute otitis mediaMedDRA version: 16.1Level: PTClassification code 10033078Term: Otitis mediaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 16.1Level: PTClassification code 10033079Term: Otitis media acuteSystem Organ Class: 10021881 - Infections and infestationsEUCTR2012-000341-13-DEWeber & Weber GmbH & Co. KG
招募中
不适用
Evaluation of Efficacy and Safety of Herbal Medicine on Work related Chronic Low Back PaiDiseases of the musculo-skeletal system and connective tissueKCT0002177Gil Korean Medicine Hospital, Gachon University72